Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam L Boxer

Showing results (21-30 of 300) with videos related to

Pageof 30
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2016
Minimal clinically important worsening on the progressive supranuclear Palsy Rating ScaleSarah Hewer, Sue Varley, Adam L Boxer, et al.
The Lancet. Neurology|February 19, 2022
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerationsBradley F Boeve, Adam L Boxer, Fiona Kumfor, et al.
Practical Neurology (Fort Washington, Pa.)|April 30, 2021
Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinicsAdam M Staffaroni, Elena Tsoy, Jack Taylor, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 18, 2020
Four-Repeat Tauopathies: Current Management and Future TreatmentsLawren VandeVrede, Peter A Ljubenkov, Julio C Rojas, et al.
Cancer Research|October 31, 2018
Tau Mutations as a Novel Risk Factor for Cancer-LetterAngela B Deutschländer, Bradley F Boeve, Howard J Rosen, et al.
Dementia and Geriatric Cognitive Disorders|October 13, 2010
Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairmentJulene K Johnson, Judy Pa, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentRebecca Snell, Brad F Boeve, Howard J Rosen, et al.
Neurocase|February 25, 2020
Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entityAndy J Liu, Jessica E Chang, Georges Naasan, et al.
The Lancet. Neurology|June 28, 2017
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approachesAdam L Boxer, Jin-Tai Yu, Lawrence I Golbe, et al.
Parkinsonism & Related Disorders|September 18, 2020
The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validationAnthony E Lang, Glenn T Stebbins, Ping Wang, et al.
Pageof 30

Showing results (21-30 of 300) with videos related to

Sort By:
Pageof 30
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2016
Minimal clinically important worsening on the progressive supranuclear Palsy Rating ScaleSarah Hewer, Sue Varley, Adam L Boxer, et al.
The Lancet. Neurology|February 19, 2022
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerationsBradley F Boeve, Adam L Boxer, Fiona Kumfor, et al.
Practical Neurology (Fort Washington, Pa.)|April 30, 2021
Digital Cognitive Assessments for Dementia: Digital assessments may enhance the efficiency of evaluations in neurology and other clinicsAdam M Staffaroni, Elena Tsoy, Jack Taylor, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 18, 2020
Four-Repeat Tauopathies: Current Management and Future TreatmentsLawren VandeVrede, Peter A Ljubenkov, Julio C Rojas, et al.
Cancer Research|October 31, 2018
Tau Mutations as a Novel Risk Factor for Cancer-LetterAngela B Deutschländer, Bradley F Boeve, Howard J Rosen, et al.
Dementia and Geriatric Cognitive Disorders|October 13, 2010
Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairmentJulene K Johnson, Judy Pa, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentRebecca Snell, Brad F Boeve, Howard J Rosen, et al.
Neurocase|February 25, 2020
Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entityAndy J Liu, Jessica E Chang, Georges Naasan, et al.
The Lancet. Neurology|June 28, 2017
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approachesAdam L Boxer, Jin-Tai Yu, Lawrence I Golbe, et al.
Parkinsonism & Related Disorders|September 18, 2020
The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validationAnthony E Lang, Glenn T Stebbins, Ping Wang, et al.
Pageof 30